Guidelines: KCE Guidelines Compilation (Belgium): Difference between revisions
From Beacon
m (Update categories.) |
m (Update categories.) Tag: Reverted |
||
| Line 35: | Line 35: | ||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | <span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | ||
<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> | <span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> | ||
<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span> | |||
<span style="display:none">hasCancerType::D10-D36: Benign tumour</span> | |||
<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span> | |||
<span style="display:none">hasCancerType::unknown</span> | |||
Revision as of 12:13, 6 December 2025
Go back to Belgium page
Primary purpose: Provides evidence-based recommendations for management, diagnosing, treating, and following up of many types of cancer.
Sponsor, manager or home institution: Federaal Kenniscentrum voor de Gezondheidszorg.
Type of information: It contains multiple guidelines about cancer diagnosis, medical procedures for treatment and periodicity of physician consultation for follow up of many types of cancers. Also, some of the guidelines include information about cancer incidence, and cancer survival by year. Click here to learn more.
Cancer areas of interest: C00-C97: All cancer types. Click here to learn more.
Access to information: Click here to access.
